Defective erythropoiesis in bone marrow is a mechanism of anemia in children with cancer.
Evaluation of the mechanism of anemia in cancer patients might help to select patients for the more efficient use of erythropoietin (EPO, a growth factor for erythroid precursor cells). For this, we investigated whether the production of EPO responds to anemia and the bone marrow responds to EPO app...
Main Authors: | , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Academy of Medical Sciences
2002
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054874/ |